L. Peyrin-Biroulet
Genetics · 2010–2020
A researcher in the Science corpus: 16 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Genetics — 237 citations into it
- Epidemiology — 139 citations into it
- Oncology — 22 citations into it
- Hepatology — 19 citations into it
Whom L. Peyrin-Biroulet trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from L. Peyrin-Biroulet's perspective
Ordered by how strongly the researchers L. Peyrin-Biroulet trusts endorse each paper. Same corpus, a different order for every researcher.
- Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease (Nature Genetics)
- Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. (Canadian journal of gastroenterology = Journal canadien de gastroenterologie)
- Identifying Relationships among Genomic Disease Regions: Predicting Genes at Pathogenic SNP Associations and Rare Deletions (PLoS Genetics)
- The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. (Gastroenterology)
- A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 (Inflammatory Bowel Diseases)
- Multiple common variants for celiac disease influencing immune gene expression (Nature Genetics)
- Unravelling the pathogenesis of inflammatory bowel disease (Nature)
- Induction and effector functions of TH17 cells (Nature)
- Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. (Cell)
- Enrichment or depletion of a GO category within a class of genes: which test?
Their papers
- Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (2011) — 1,319 citations
- Ulcerative colitis (2020) — 1,082 citations
- STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. (2020) — 2,231 citations
- Crohn’s disease (2020) — 686 citations
- Application of Artificial Intelligence to Gastroenterology and Hepatology. (2019) — 425 citations
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. (2019) — 919 citations
- Multiple Sclerosis Genomic Map implicates peripheral immune cells & microglia in susceptibility (2019) — 1,186 citations
- Environmental Risk Factors for Inflammatory Bowel Diseases: an Umbrella Review of Meta-analyses. (2019) — 610 citations
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management (2017) — 1,770 citations
- Crohn's disease (2017) — 1,297 citations
- Ulcerative colitis (2017) — 1,593 citations
- Iron deficiency anaemia. (2016) — 775 citations
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target (2015) — 1,734 citations
- Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. (2013) — 695 citations
- Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. (2012) — 908 citations
- The Natural History of Adult Crohn's Disease in Population-Based Cohorts (2010) — 993 citations